Featured Publications
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
Choi C, Ganji SK, Deberardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, Yang XL, Mashimo T, Raisanen JM, Marin-Valencia I, Pascual JM, Madden CJ, Mickey BE, Malloy CM, Bachoo RM, Maher EA Nature medicine 2012 Jan
A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
Leacock SW, Basse AN, Chandler GL, Kirk AM, Rakheja D, Amatruda JF Dis Model Mech 2012 Jan 5 1 95-106
Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours.
Fustino N, Rakheja D, Ateek CS, Neumann JC, Amatruda JF Int. J. Androl. 2011 Aug 34 4 Pt 2 e218-33
Mutation in the type IB bone morphogenetic protein receptor alk6b impairs germ-cell differentiation and causes germ-cell tumors in zebrafish.
Neumann JC, Chandler GL, Damoulis VA, Fustino NJ, Lillard K, Looijenga L, Margraf L, Rakheja D, Amatruda JF Proceedings of the National Academy of Sciences of the United States of America 2011 Jul 13153-8
High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.
Paulson V, Chandler G, Rakheja D, Galindo RL, Wilson K, Amatruda JF, Cameron S Genes Chromosomes Cancer 2011 Jun 50 6 397-408
High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.
Rakheja D, Konoplev S, Su M, Wheeler D, Muzny DM, Ruvolo VR, Collins R, Karandikar NJ, Andreeff M, Medeiros LJ, Chen W British journal of haematology 2011 Apr 125-8
CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 desaturase.
Narayan SB, Rakheja D, Tan L, Pastor JV, Bennett MJ Ann. Neurol. 2006 Nov 60 5 570-7
Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age.
Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB Placenta 2002 May 23 5 447-50
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK Am. J. Pathol. 2011 Oct 179 4 1608-15
TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
Cost NG, Mitui M, Khokhar S, Wickiser JE, Baker LA, Rakheja D Pediatr Blood Cancer 2011 Aug
